These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 9336418

  • 1. Clinical, laboratory, radiographic, and histopathologic features of methotrexate-associated lung injury in patients with rheumatoid arthritis: a multicenter study with literature review.
    Kremer JM, Alarcón GS, Weinblatt ME, Kaymakcian MV, Macaluso M, Cannon GW, Palmer WR, Sundy JS, St Clair EW, Alexander RW, Smith GJ, Axiotis CA.
    Arthritis Rheum; 1997 Oct; 40(10):1829-37. PubMed ID: 9336418
    [Abstract] [Full Text] [Related]

  • 2. Methotrexate-induced acute lung injury in a patient with rheumatoid arthritis.
    Taniguchi K, Usui Y, Matsuda T, Suzuki S, Fujiki K, Yakusiji F, Tomiyama J, Kinoshita K, Ilzuka H, Kuga Y.
    Int J Clin Pharmacol Res; 2005 Oct; 25(3):101-5. PubMed ID: 16366417
    [Abstract] [Full Text] [Related]

  • 3. Methotrexate-induced pneumonitis in patients with rheumatoid arthritis and psoriatic arthritis: report of five cases and review of the literature.
    Salaffi F, Manganelli P, Carotti M, Subiaco S, Lamanna G, Cervini C.
    Clin Rheumatol; 1997 May; 16(3):296-304. PubMed ID: 9184269
    [Abstract] [Full Text] [Related]

  • 4. Methotrexate pulmonary toxicity.
    Cannon GW.
    Rheum Dis Clin North Am; 1997 Nov; 23(4):917-37. PubMed ID: 9361161
    [Abstract] [Full Text] [Related]

  • 5. Risk factors for methotrexate-induced lung injury in patients with rheumatoid arthritis. A multicenter, case-control study. Methotrexate-Lung Study Group.
    Alarcón GS, Kremer JM, Macaluso M, Weinblatt ME, Cannon GW, Palmer WR, St Clair EW, Sundy JS, Alexander RW, Smith GJ, Axiotis CA.
    Ann Intern Med; 1997 Sep 01; 127(5):356-64. PubMed ID: 9273826
    [Abstract] [Full Text] [Related]

  • 6. Is incident rheumatoid arthritis interstitial lung disease associated with methotrexate treatment? Results from a multivariate analysis in the ERAS and ERAN inception cohorts.
    Kiely P, Busby AD, Nikiphorou E, Sullivan K, Walsh DA, Creamer P, Dixey J, Young A.
    BMJ Open; 2019 May 05; 9(5):e028466. PubMed ID: 31061059
    [Abstract] [Full Text] [Related]

  • 7. The first double-blind, randomised, parallel-group certolizumab pegol study in methotrexate-naive early rheumatoid arthritis patients with poor prognostic factors, C-OPERA, shows inhibition of radiographic progression.
    Atsumi T, Yamamoto K, Takeuchi T, Yamanaka H, Ishiguro N, Tanaka Y, Eguchi K, Watanabe A, Origasa H, Yasuda S, Yamanishi Y, Kita Y, Matsubara T, Iwamoto M, Shoji T, Okada T, van der Heijde D, Miyasaka N, Koike T.
    Ann Rheum Dis; 2016 Jan 05; 75(1):75-83. PubMed ID: 26139005
    [Abstract] [Full Text] [Related]

  • 8. Occurrence of pulmonary complications during methotrexate therapy in rheumatoid arthritis.
    Hilliquin P, Renoux M, Perrot S, Puéchal X, Menkès CJ.
    Br J Rheumatol; 1996 May 05; 35(5):441-5. PubMed ID: 8646434
    [Abstract] [Full Text] [Related]

  • 9. Effectiveness, tolerability, and safety of subcutaneous methotrexate in early rheumatoid arthritis: A retrospective analysis of real-world data from the St. Gallen cohort.
    Müller RB, von Kempis J, Haile SR, Schiff MH.
    Semin Arthritis Rheum; 2015 Aug 05; 45(1):28-34. PubMed ID: 25895697
    [Abstract] [Full Text] [Related]

  • 10. Abatacept plus methotrexate provides incremental clinical benefits versus methotrexate alone in methotrexate-naive patients with early rheumatoid arthritis who achieve radiographic nonprogression.
    Wells AF, Westhovens R, Reed DM, Fanti L, Becker JC, Covucci A, Keystone EC.
    J Rheumatol; 2011 Nov 05; 38(11):2362-8. PubMed ID: 21885491
    [Abstract] [Full Text] [Related]

  • 11. Clinical, functional, and radiographic benefits of longterm adalimumab plus methotrexate: final 10-year data in longstanding rheumatoid arthritis.
    Keystone EC, van der Heijde D, Kavanaugh A, Kupper H, Liu S, Guérette B, Mozaffarian N.
    J Rheumatol; 2013 Sep 05; 40(9):1487-97. PubMed ID: 23818718
    [Abstract] [Full Text] [Related]

  • 12. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
    Cohen S, Cannon GW, Schiff M, Weaver A, Fox R, Olsen N, Furst D, Sharp J, Moreland L, Caldwell J, Kaine J, Strand V.
    Arthritis Rheum; 2001 Sep 05; 44(9):1984-92. PubMed ID: 11592358
    [Abstract] [Full Text] [Related]

  • 13. [Toxicity of low-dose methotrexate in rheumatoid arthritis--clinical characteristics in patients with MTX-induced pancytopenia and interstitial pneumonitis].
    Ohosone Y, Okano Y, Kameda H, Hama N, Matsumura M, Nojima T, Nakamura K, Kuwana M, Ogasawara T, Hirakata M, Yoshida T, Mimori T, Akizuki M, Ikeda Y.
    Ryumachi; 1997 Feb 05; 37(1):16-23. PubMed ID: 9128419
    [Abstract] [Full Text] [Related]

  • 14. Low-dose prednisone inclusion in a methotrexate-based, tight control strategy for early rheumatoid arthritis: a randomized trial.
    Bakker MF, Jacobs JW, Welsing PM, Verstappen SM, Tekstra J, Ton E, Geurts MA, van der Werf JH, van Albada-Kuipers GA, Jahangier-de Veen ZN, van der Veen MJ, Verhoef CM, Lafeber FP, Bijlsma JW, Utrecht Rheumatoid Arthritis Cohort Study Group.
    Ann Intern Med; 2012 Mar 06; 156(5):329-39. PubMed ID: 22393128
    [Abstract] [Full Text] [Related]

  • 15. Methotrexate update.
    Kremer JM.
    Scand J Rheumatol; 1996 Mar 06; 25(6):341-4. PubMed ID: 8996467
    [Abstract] [Full Text] [Related]

  • 16. Radiographic progression in early rheumatoid arthritis: a 12-month randomized controlled study comparing the combination of cyclosporin and methotrexate with methotrexate alone.
    Marchesoni A, Battafarano N, Arreghini M, Panni B, Gallazzi M, Tosi S.
    Rheumatology (Oxford); 2003 Dec 06; 42(12):1545-9. PubMed ID: 12810924
    [Abstract] [Full Text] [Related]

  • 17. Pulmonary function in patients receiving long-term low-dose methotrexate.
    Cottin V, Tébib J, Massonnet B, Souquet PJ, Bernard JP.
    Chest; 1996 Apr 06; 109(4):933-8. PubMed ID: 8635373
    [Abstract] [Full Text] [Related]

  • 18. Do impaired memory, cognitive dysfunction and distress play a role in methotrexate-related neutropenia in rheumatoid arthritis patients? A comparative study.
    Pamuk ON, Kisacik B, Pamuk GE, Onat AM, Sayarlioglu M, Donmez S, Pehlivan Y, Keystone EC.
    Rheumatol Int; 2013 Oct 06; 33(10):2631-5. PubMed ID: 23743624
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: a double-blind, randomized, placebo-controlled trial.
    van Dongen H, van Aken J, Lard LR, Visser K, Ronday HK, Hulsmans HM, Speyer I, Westedt ML, Peeters AJ, Allaart CF, Toes RE, Breedveld FC, Huizinga TW.
    Arthritis Rheum; 2007 May 06; 56(5):1424-32. PubMed ID: 17469099
    [Abstract] [Full Text] [Related]

  • 20. Clinical characteristics and risk factors for low dose methotrexate toxicity: a cohort of 28 patients.
    Kivity S, Zafrir Y, Loebstein R, Pauzner R, Mouallem M, Mayan H.
    Autoimmun Rev; 2014 Nov 06; 13(11):1109-13. PubMed ID: 25172240
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.